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Common variants in LEPR, IL6, AMD1,
and NAMPT do not associate with risk of
juvenile and childhood obesity in Danes:
a case–control study
Mette Hollensted1†, Tarunveer S Ahluwalia1,2,3*†, Christian Theil Have1, Niels Grarup1, Cilius Esmann Fonvig1,4,
Tenna Ruest Haarmark Nielsen1,4, Cæcilie Trier1,4, Lavinia Paternoster5, Oluf Pedersen1, Jens-Christian Holm5,
Thorkild I A Sørensen1,5,6 and Torben Hansen1
Abstract
Background: Childhood obesity is a highly heritable disorder, for which the underlying genetic architecture is
largely unknown. Four common variants involved in inflammatory-adipokine triggering (IL6 rs2069845, LEPR
rs1137100, NAMPT rs3801266, and AMD1 rs2796749) have recently been associated with obesity and related traits in
Indian children. The current study aimed to examine the effect of these variants on risk of childhood/juvenile onset
obesity and on obesity-related quantitative traits in two Danish cohorts.
Methods: Genotype information was obtained for 1461 young Caucasian men from the Genetics of Overweight
Young Adults (GOYA) study (overweight/obese: 739 and normal weight: 722) and the Danish Childhood Obesity
Biobank (TDCOB; overweight/obese: 1022 and normal weight: 650).
Overweight/obesity was defined as having a body mass index (BMI) ≥25 kg/m2; among children and youths, this
cut-off was defined using age and sex-specific cut-offs corresponding to an adult body mass index ≥25 kg/m2.
Risk of obesity was assessed using a logistic regression model whereas obesity-related quantitative measures were
analyzed using a general linear model (based on z-scores) stratifying on the case status and adjusting for age and
gender. Meta-analyses were performed using the fixed effects model.
Results: No statistically significant association with childhood/juvenile obesity was found for any of the four gene
variants among the individual or combined analyses (rs2069845 OR: 0.94 CI: 0.85–1.04; rs1137100 OR: 1.01 CI: 0.90–1.14;
rs3801266: 0.96 CI: 0.84–1.10; rs2796749 OR: 1.02 CI: 0.90–1.15; p > 0.05). However, among normal weight children and
juvenile men, the LEPR rs1137100 A-allele significantly associated with lower BMI (β = −0.12, p = 0.0026).
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Conclusions: The IL6, LEPR, NAMPT, and AMD1 gene variants previously found to associate among Indian children did
not associate with risk of obesity or obesity-related quantitative measures among Caucasian children and juvenile men
from Denmark.
Keywords: Childhood obesity, Juvenile obesity, Single nucleotide polymorphism, Case-control study, Body mass index,
BMI, Obesity
Background
The burden of childhood obesity has increased dramat-
ically within the past two decades and as of today one in
every three children (6–9 years old) within the European
Union is overweight or obese [1]. Childhood obesity is
associated with numerous related complications and
serious diseases later in life, including cardiovascular
disease [2], type 2 diabetes, several cancers and rheuma-
tologic disorders, as well as social stigmatization and
psychological health problems [3, 4]. Although the re-
cent increase in the prevalence of childhood obesity is
most likely a result of environmental changes, a genetic
component contributing to the risk of obesity is also
evident from twin studies [5, 6]. To date, genome-wide
association studies (GWAS) have identified well over
100 adiposity susceptibility loci [7, 8], however, only a
limited number of these have been implicated in child-
hood obesity [9–11].
Recent studies suggest that white adipose tissue in-
flammation has an emerging role in obesity pathophysi-
ology [12]. White adipose tissue plays an important role
in the production of bioactive adipokines that possess
immune-regulatory properties in addition to regulation
of systemic metabolism. A recent study explored the role
of genes encoding adipokines and inflammatory markers
(interleukin 6, IL6; leptin receptor, LEPR, and nicotina-
mide phosphoribosyltransferase, NAMPT) in 2,261 nor-
mal weight and 907 overweight/obese children of Indian
origin (age range: 11–17 years). Overweight/obesity was
defined using age and sex-specific cut-offs corresponding
to a BMI ≥25 kg/m2 in adults [13]. When employing a
two stage study design, all three variants (IL6, LEPR, and
NAMPT) were found to associate with an increased
prevalence of childhood obesity (ORcombined >1.35) and
related quantitative measures (BMI, weight, waist and
hip circumference, p ≤ 2.0 × 10−3) [14].
A follow-up study in the Indian cohort reported the
AMD1gene (adenosylmethionine decarboxylase 1) single
nucleotide polymorphism (SNP) rs2796749 G allele to
be associated with childhood obesity (OR = 1.35; p = 1.9 ×
10−6) and related quantitative measures (BMI, weight,
height, waist and hip circumference, as well as plasma
leptin levels (p ≤ 6.7 × 10−4) [15]. AMD1 encodes an im-
portant intermediate enzyme involved in the homocyst-
eine pathway.
Previous studies examining the effect of IL6, LEPR,
NAMPT, and AMD1 variants on risk of childhood obes-
ity in Caucasians are very limited and have generally
been small and statistically underpowered [16, 17]. Thus,
the aim of the present study was to replicate the findings
by Tabassum et al. [14, 15] by examining the effect of
four SNPs: IL6 rs2069845, LEPR rs1137100, NAMPT
rs3801266, and AMD1 rs2796749 on the risk of child-
hood/juvenile obesity and anthropometric traits (BMI,
height, and weight) in the two Danish study populations
comprising cases of childhood or juvenile obesity and
normal weight controls.
Methods
The present study was conducted in accordance with the
Helsinki declaration and approved by the Danish Data
Protection Agency and by the regional scientific ethics
committees. Prior to this study, all participants aged 18 or
parents of younger children signed an informed written
consent.
Study participants
GOYA male
In the recruitment of these participants, a case-cohort
sampling design was employed in which cases were de-
fined as the individuals with the upper-most extreme BMI
in the cohort, and controls were randomly selected from
the same cohort [18].
During 1943–1977, 362200 Caucasian men with a mean
age of ~20 years were examined at draft boards in the area
of Copenhagen, Denmark. At the draft board examina-
tions, standing height (without shoes) and weight (in
underwear only) were measured. Obesity was defined as
35 % overweight relative to a local standard in use at the
time (mid 1970’s). This definition corresponds to a BMI
≥31.0 kg/m2, which proved to be above the 99th percent-
ile. All obese men (n = 1930) and a randomly selected
control group (n = 3601), comprising one percent of all
participants, were sampled on the basis of the records
from the draft board examinations.
In 1991–1994, at the mean age of 46 years, all obese
men and 50 % of the randomly selected young men from
the study population were invited for a follow-up survey
(753 obese and 879 control men attended), at which
time non-fasting venous blood samples were obtained
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[19]. By using a sampling fraction of 0.5 % (50 % of 1 %),
the included controls effectively represent approximately
158000 men among whom the case group was the most
obese. Criteria for invitation to follow-up surveys and
participation have been described elsewhere [20].
In the current study, while replicating the original
studies by Tabassum et al. [14, 15], we adopted the BMI
cut-off corresponding to overweight/obesity defined as
BMI ≥25 kg/m2, and 1461 (noverweight/obese: 739 and
nnormal weight: 722) men had complete genetic and pheno-
typic information representing the GOYA (male) cohort.
The Danish Childhood Obesity Biobank (TDCOB)
All children were recruited through The Children’s
Obesity Clinic, Copenhagen University Hospital Holbæk,
Denmark. Obese children, defined by a BMI above the
90th percentile for age and sex according to Danish stand-
ard BMI charts [21], aged 3 to 18 years were treated using
the Children’s Obesity Clinic’s Treatment Protocol [22]. In
addition, an age and gender matched control group was
recruited from schools and high schools in the surround-
ing area.
Height and weight were measured to the nearest
0.1 cm and 0.1 kg, respectively, using an integrated cali-
brated weight and stadiometer (ADE, Modell MZ10023,
Germany) while wearing light indoor clothing. Danish
standard BMI charts [21] were used to calculate BMI
(kg/m2) into BMI z-scores. Prior to analysis, children
with syndromes (e.g. Turner syndrome, Down’s syndrome)
or other clinical diagnoses known to associate with obesity
were excluded.
A total of 1672 children (noverweight/obese: 1022 and
nnormal weight: 650), from the TDCOB cohort participated
in the current study.
Clinical characteristics for both study populations are
listed in Table 1.
Genotyping
GOYA (Male)
Genotyping on the Illumina Human 610 k quad bead chip
was performed at the Centre National de Génotypage,
Evry, France. Genotypes were called using the Gen Call
algorithm from Genome Studio package. In brief, the data
quality control included 1) exclusion of SNPs with a
minor allele frequency <1% and >5 % missing geno-
types, 2) exclusion of those failing Hardy Weinberg
equilibrium (HWE, p < 10−7), and 3) including only
European individuals (clustering with the HapMap
CEU population (Utah residents with Northern and west-
ern European ancestry)). Further checks on heterozygos-
ity, sample duplicates, individual relatedness, or with sex
discrepancy were made. Imputation was carried out to
HapMap release 22 (CEU individuals) using Mach 1.0,
Markov Chain Haplotyping [23].
Finally, we extracted genotypes for two SNPs (LEPR
rs1137100 and AMD1 rs2796749) available on the SNP
array, whereas the other two (IL6 rs2069845, NAMPT
rs3801266) were imputed with an r2 ≥ 0.8.
TDCOB
The SNPs were genotyped on Illumina Infinium Human-
CoreExome Beadchip platform at the Novo Nordisk
Foundation Centre for Basic Metabolic Research’s labora-
tory at Symbion, Copenhagen, Denmark. Genotypes were
called with Illumina standard pipeline in Genome Studio.
The data quality control involved 1) HWE filter: variants
with pHWE >0.005 were retained, 2) ethnicity checks using
principal component analyses were performed, and indi-
viduals identified as ethnic outliers or with extreme
positive or negative inbreeding coefficients were removed.
Checks on heterozygosity, sample duplicates, or with sex
discrepancy were made. Additional genotypes were im-
puted into 1000 genomes phase 1 [24] using impute2 [25].
All variants examined in the current study were imputed
with high quality (info >0.95). In case of siblings, only
the sibling with the best overall genotype call-rate was
retained in the study (regardless of gender).
Statistical analyses
The quantitative measures were transformed to z-scores
(standard deviations (sd) from the study reference group
(controls) mean) using the equation z (z-score) = (x − μ)/σ
where x is the raw measure, μ is the mean value for the
Table 1 Clinical characteristics of participants from the GOYA
(male) and the TDCOB study
Characteristics GOYA TDCOB
Ntotal (%men) 1461 (100) 1672 (41.9)
Noverweight/obese/Nnormal weight 739/722 1022/650
Ageoverweight/obese 19.9 ± 1.9 11.7 ± 3.2
Agenormal weight 19.9 ± 1.7 12.7 ± 3.3
BMIoverweight/obese 32.6 ± 3.0 27.2 ± 5.8
zBMIoverweight/obese 6.4 ± 1.6 2.8 ± 0.70
BMInormal weight 21.1 ± 1.7 18.4 ± 2.7
zBMInormal weight 0.04 ± 1.0 0.11 ± 0.89
Heightoverweight/obese 177.3 ± 6.1 153.3 ± 16.3
zHeightoverweight/obese 0.10 ± 0.9 0.96 ± 0.98
Heightnormal weight 176.7 ± 6.6 155.4 ± 16.3
zHeightnormal weight 0.007 ± 1.0 0.66 ± 0.99
Weightoverweight/obese 102.7 ± 11.5 66.5 ± 25.6
zWeight overweight/obese 5.28 ± 1.6 4.0 ± 0.52
Weightnormal weight 66.1 ± 6.9 45.9 ± 14.5
zWeightnormal weight 0.011 ± 1.0 3.86 ± 0.51
Data are means ± standard deviations. Individuals were classified as being
overweight/obese or normal weight using age and sex-specific cut-offs
corresponding to a BMI ≥25 kg/m2 in adults
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study reference group, and σ is the sd for that reference
group. Logistic regression was used to compare allele
frequencies in the dichotomized case–control groups
whereas a general linear model was applied to test quanti-
tative traits using an additive genetic model while adjust-
ing for age and gender. For these analyses, we adopted
both the age and gender dependent BMI cut-off corre-
sponding to an adult BMI ≥25 kg/m2 provided by Cole et
al. [13] as per the studies by Tabassum et al. [14, 15], as
well as a BMI cut-off of 31 kg/m2, taking into account the
original GOYA study design. No transformation of traits
was performed as they followed normal distributions
within case or control groups. Linear regression analyses
were performed separately in the case and cohort groups
owing to the trait distribution as per study design. A
p-value of less than 0.05 was considered statistically
significant. Association tests were conducted on the
imputed genotype likelihoods using the frequentist score
method of the SNPtest tool (version 2.5) with a standard
additive model among TDCOB children and using R stat-
istical software (version 2.12.1) [26] in the GOYA males.
We combined the individual study results (obesity risk
and quantitative trait (zBMI, zWeight, zHeight) associ-
ation results) to perform a fixed effects (inverse variance)
meta-analysis where weights are proportional to the
squared standard error of the effect estimates, as imple-
mented in the METAL software [27]. The heterogeneity in
effect sizes across the two participating cohorts was evalu-
ated using the chi-square test for heterogeneity (I2) also
through METAL.
External data look-up
External data from published GWAS meta-analyses on
BMI was contributed by GIANT consortia investigators
and was freely accessible [28].
Results
Association with obesity
We found no association between the four genetic loci
(IL6 rs2069845, LEPR rs1137100, NAMPT rs3801266, and
AMD1 rs2796749) and prevalence of obesity (correspond-
ing to an adult BMI cut-off of 25 kg/m2) among Danish
young men or children (Table 2). We also checked for
associations taking into account the original GOYA study
design (corresponding to a BMI cut-off of 31 kg/m2)
but the results remained insignificant (p > 0.05; data
not shown).
Furthermore, no statistically significant association with
obesity was found for either of the variants in the com-
bined analyses (rs2069845: OR [95 % CI] = 0.94 [0.85–
1.04], pcombined = 0.24; rs1137100: OR [95 % CI] = 1.01
[0.90–1.14], pcombined = 0.46; rs3801266: OR [95 % CI] =
0.96 [0.84–1.10], pcombined = 0.58; and rs2796749: OR
[95 % CI] = 1.02 [0.90–1.15], pcombined = 0.68; Table 2).
Association with obesity-related quantitative traits
We then examined the four SNPs for association with
obesity-related traits (zBMI, zHeight, and zWeight) in the
normal weight and overweight/obese groups separately.
Among the normal weight juvenile men, the LEPR
rs1137100 A-allele significantly associated with zBMI
(β = −0.17, pGOYA = 0.0036), and this association remained
significant in the combined analyses (β = −0.12, pcombined =
0.0026; Table 3).
Furthermore, we observed some cohort specific associa-
tions that did not reach statistical significance in the com-
bined analyses. Among GOYA, the LEPR SNP associated
with reduced zWeight (β = −0.12, pGOYA = 0.046) whereas
the AMD1 rs2796749 associated with zHeight (β = −0.14,
pGOYA = 0.017; Table 3). While taking the original study
design for GOYA into account (BMI cut-off of 31 kg/m2),
we found similar associations for LEPR rs1137100 with
zBMI and zWeight (βGOYA_zBMI = −0.14, pGOYA_zBMI =
0.014; and βGOYA_zWeight = −0.11, pGOYA_zWeight = 0.045)
whereas non-significant for AMD1 rs2796749 and zHeight
(p > 0.05) (data not shown).
In TDCOB, AMD1 rs2796749 was found to associ-
ate with zBMI (β = −0.16, pTDCOB = 0.0077) while IL6
rs2069845 modestly associated with zHeight (β = −0.05,
p = 0.047; Table 3).
Among the overweight/obese individuals, no significant
association with zBMI, zWeight or zHeight was identified
in either of the examined cohorts or in the combined
analysis (Table 4). A p-value corresponding to each chi-
square test for heterogeneity has also been indicated
(PHET) in the results tables (Tables 2, 3, and 4).
Discussion
Common variations in four genes involved in inflamma-
tory and homocysteine pathways (IL6, LEPR, NAMPT,
and AMD1) have recently been shown to associate with
childhood obesity among children of Indian origin [14, 15].
We aimed to replicate these findings, however, we found
none of the variants to exert a strong effect on risk of obes-
ity among Danish children and juveniles (OR ≤1.15, as
based on 95 % CI, Table 2). We did, however, observe a
modest association between the LEPR variant and lowered
BMI among non-obese Danish children and young men,
albeit the directionality of these associations was opposite
to what was observed among Indian children [14]. In
the studies by Tabassum et al., IL6, LEPR, and NAMPT
variants also associated with hip and waist circumference
[14, 15], but unfortunately, information on these traits
were not available in the present study.
LEPR is involved in the regulation of fat metabolism,
and although mutations in LEPR robustly associate with
monogenic forms of obesity [29, 30], studies focusing on
complex forms of obesity report conflicting results for
several variants, including Q223R, K109R and K656N, in
Hollensted et al. BMC Medical Genetics  (2015) 16:105 Page 4 of 9
Table 2 Association with obesity: Case–control analysis in GOYA (male) and TDCOB study participants
SNP Locus Alleles
(effect/other)
GOYA (n = 1461) TDCOB (n = 1672) Combined (n = 3133)
n
(cases/controls)
EAF
(cases/controls)
p OR (95 % CI) n
(cases/controls)
EAF
(cases/controls)
p OR (95 % CI) n
(cases/controls)
p OR (95 % CI) I2 (pHET)
rs2069845 IL6 G/A 739/722 0.49/0.49 0.88 0.98 (0.85–1.14) 1022/650 0.47/0.49 0.13 0.88 (0.76–1.01) 1761/1372 0.24 0.94 (0.85–1.04) 0 (0.35)
rs1137100 LEPR A/G 739/722 0.74/0.74 0.69 0.96 (0.81–1.14) 1022/650 0.75/0.74 0.42 1.05 (0.90–1.23) 1761/1372 0.46 1.01 (0.90–1.14) 0 (0.40)
rs3801266 NAMPT T/C 739/722 0.82/0.83 0.96 0.99 (0.82–1.20) 1022/650 0.83/0.84 0.47 0.92 (0.76–1.11) 1761/1372 0.58 0.96 (0.84–1.10) 0 (0.63)
rs2796749 AMD1 G/C 739/722 0.78/0.78 0.94 1.0 (0.84–1.19) 1022/650 0.79/0.78 0.59 1.03 (0.87–1.22) 1761/1372 0.68 1.02 (0.90–1.15) 7 (0.73)
Cases and controls were defined using age and sex-specific cut-offs corresponding to a BMI ≥25 kg/m2 in adults. p-values are for an additive genetic model and are adjusted for age
EAF Effect allele frequency, BMI body mass index, CI confidence interval, HET heterogeneity, OR Odds Ratio, SNP single nucleotide polymorphism
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adults [31–33]. Reported LEPR associations with obesity
among children and adolescents have also been inconsist-
ent: Mexican (n = 128) and Polish (n = 142) studies found
no association between LEPR rs1137100 [K109R] and
obesity [16, 34], whereas a small study of 136 Japanese
children found the rs1137100 A-allele to associate with in-
creased risk of being overweight [35]. In the current study,
the rs1137100 A-allele associated significantly with a low-
ered BMI but not with obesity. However, this result was
primarily driven by the normal weight juvenile men and
Table 3 Association with quantitative traits in 1372 normal weight individuals
SNP Locus Alleles
(effect/other)
Effect allele
frequency
GOYA (n = 722) TDCOB (n = 650) Combined (n = 1372)
β SE p β SE p β SE p I2 (pHET)
zBMI
rs2069845 IL6 G/A 0.49 0.04 0.05 0.34 −0.02 0.05 0.62 0.01 0.04 0.76 3 (0.31)
rs1137100 LEPR A/G 0.74 −0.17 0.06 0.0036 −0.08 0.06 0.15 −0.12 0.04 0.0026 20 (0.26)
rs3801266 NAMPT T/C 0.83 −0.03 0.07 0.58 0.04 0.07 0.51 0.01 0.05 0.93 0 (0.39)
rs2796749 AMD1 G/C 0.78 0.03 0.06 0.60 −0.16 0.06 0.0077 −0.06 0.04 0.12 80 (0.03)
zHeight
rs2069845 IL6 G/A 0.49 0.02 0.05 0.65 −0.07 0.06 0.19 −0.02 0.04 0.56 36 (0.20)
rs1137100 LEPR A/G 0.74 0.01 0.06 0.63 −0.08 0.06 0.17 −0.04 0.04 0.36 5 (0.30)
rs3801266 NAMPT T/C 0.83 0.07 0.07 0.32 −0.12 0.08 0.12 −0.02 0.05 0.75 69 (0.07)
rs2796749 AMD1 G/C 0.78 −0.12 0.06 0.046 0.10 0.07 0.15 −0.02 0.05 0.64 82 (0.01)
zWeight
rs2069845 IL6 G/A 0.49 0.06 0.05 0.29 −0.05 0.03 0.047 −0.03 0.02 0.19 69 (0.06)
rs1137100 LEPR A/G 0.74 −0.14 0.06 0.017 −0.02 0.03 0.44 −0.05 0.03 0.08 68 (0.07)
rs3801266 NAMPT T/C 0.83 0.02 0.07 0.82 −0.01 0.04 0.79 −0.01 0.03 0.89 0 (0.75)
rs2796749 AMD1 G/C 0.78 −0.07 0.06 0.29 −0.01 0.03 0.95 −0.01 0.03 0.66 0 (0.33)
Effect sizes (β), standard error (SE) and p-values are for an additive genetic model based on z-scores of each trait and are adjusted for age. Effect allele frequency
is the mean frequency observed for the GOYA and TDCOB cohort control individuals. Padd < 0.05 is significant and is shown in bold. Values of I
2 are percentages
BMI body mass index, CI confidence interval, HET heterogeneity, SE standard error, SNP single nucleotide polymorphism
Table 4 Association with quantitative traits in 1761 overweight/obese individuals
SNP Locus Alleles
(Effect/other)
Effect allele
frequency
GOYA (n = 739) TDCOB (n = 1022) Combined (n = 1761)
β SE p β SE p β SE p I2 (pHET)
zBMI
rs2069845 IL6 G/A 0.48 0.02 0.09 0.78 0.01 0.03 0.90 0.01 0.03 0.84 0 (0.83)
rs1137100 LEPR A/G 0.74 0.11 0.10 0.28 −0.01 0.03 0.71 0.01 0.03 0.99 20 (0.26)
rs3801266 NAMPT T/C 0.83 −0.09 0.12 0.45 −0.05 0.04 0.19 −0.06 0.04 0.13 0 (0.77)
rs2796749 AMD1 G/C 0.78 −0.11 0.11 0.31 −0.06 0.04 0.08 −0.07 0.04 0.05 0 (0.69)
zHeight
rs2069845 IL6 G/A 0.48 0.04 0.05 0.39 −0.01 0.04 0.79 0.01 0.03 0.70 0 (0.41)
rs1137100 LEPR A/G 0.74 0.05 0.05 0.35 −0.05 0.05 0.28 −0.01 0.04 0.89 49 (0.16)
rs3801266 NAMPT T/C 0.83 −0.04 0.06 0.54 −0.02 0.06 0.70 −0.03 0.04 0.48 0 (0.85)
rs2796749 AMD1 G/C 0.78 0.05 0.06 0.43 −0.04 0.05 0.51 0.01 0.04 0.94 2 (0.31)
zWeight
rs2069845 IL6 G/A 0.48 0.07 0.09 0.41 −0.02 0.02 0.46 −0.01 0.02 0.61 0 (0.33)
rs1137100 LEPR A/G 0.74 0.13 0.10 0.19 0.02 0.03 0.45 0.03 0.03 0.28 11 (0.28)
rs3801266 NAMPT T/C 0.83 −0.11 0.11 0.33 0.03 0.03 0.38 0.02 0.03 0.54 24 (0.25)
rs2796749 AMD1 G/C 0.78 −0.03 0.11 0.75 0.02 0.03 0.56 0.01 0.03 0.63 0 (0.65)
Effect sizes (β), standard error (SE) and p-values are for an additive genetic model based on z-scores of each trait and is adjusted for age. Effect allele frequency is
the mean frequency observed for the GOYA and TDCOB cohort obese individuals. Padd < 0.05 is significant. Values of I
2 are percentages
Add additive, BMI body mass index, CI confidence interval, HET heterogeneity, SE standard error, SNP single nucleotide polymorphism
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not by the children. These inconsistent findings could imply
that the effects of rs1137100 may get modified by additional
genetic or environmental factors which may vary between
populations. Recent studies in Europeans have suggested
obesity related measures to be influenced by interactions
between LEPR polymorphisms and a polymorphism of
the tyrosine phosphatase 1B [36] and ponderal index
[37] and future studies focusing on such “gene-gene”
and “gene-environment” interactions are thus warranted.
In the current study, no association with obesity was
identified for the IL6 variant in the individual cohorts or
in the combined analysis. Previous studies examining the
putative association between variations in the promoter
region of IL6 and risk of obesity in adults have yielded
contradictive results [32, 38–40], and studies among
children are limited. Reports on Mexican adolescents
(age range: 14–19 years) found IL6 variants (rs1800795,
rs1800796, and rs1800797) to associate with quantitative
obesity-related traits and prevalence of obesity [41]. Simi-
larly, a study on Greek primary school children (n = 184)
reported rs1800795 to associate with obesity-related traits
[42]. In the HapMap database, rs1800795 and rs1800797
(for CEU population) are both in relatively high linkage
disequilibrium (LD) with rs2069845 (r2 > 0.83, D’ > 0.93)
which was examined in the present study. The inconsist-
ency between study results may be due to differences in
age or gender stratification in the examined study popula-
tions, and/or it may relate to statistical power issues.
Variations in NAMPT have in recent studies in German
and Brazilian children and adolescents not associated with
risk of obesity [17, 43] and the similar was observed in the
current study involving Danes. However, a French study
including children and adults reported a rare NAMPT
variant (rs10487818) associating with decreased risk of
obesity [44]. Since the rare variant (rs10487818) examined
among French [44] was unavailable in our study and
in the Exome variant server [45], it may represent a
population-specific signal.
Albeit we found no association between AMD1
rs2796749 and risk of obesity, the AMD1 (rs2796749) G-
allele strongly correlated with a lower zBMI among the
TDCOB non-obese children and borderline with the
TDCOB obese children but not among the GOYA men,
suggesting some protective effect of AMD1 SNP on BMI
among children but not young men. Again, it is note-
worthy that the AMD1 G-allele associated with a lower
zBMI among Danish TDCOB children whereas direction-
ality of effect among Indian children was opposite. As
the first study to report an association between an
AMD1 variant and childhood obesity, Tabassum et al.
identified a relatively high OR (1.35, p = 1.9 × 10−6) for
AMD1 rs2796749 [11], perhaps reflecting a case of “win-
ner’s curse”, or it may indicate that the effect of AMD1
rs2796749 is population-specific.
All of the four SNPs examined in the present study
were included in both a large meta-analysis (n = 249796)
of European-ancestry-based GWAS [46], and a more
recent combined GWAS and Metabochip meta-analysis
(n = 339224) [8]. Both studies were performed in adults,
and no statistically significant association with BMI was
observed for any of the variants [8, 46], suggesting
that none of the four variants significantly influence
the risk of obesity in adulthood and that putative ef-
fects may be exerted only in childhood. Although the
GOYA study participants were sampled at ~20 years
of age, the group of overweight/obese individuals already
had a much increased BMI at age seven years, compared
to the population sample and this deviation increased as
the children grew older [47]. However, BMI data from age
seven years were only available in a subset (n ~ 172 in each
group) compared to available data at mean age 20 years
(n ~ 722 in each group). For that reason we define the
individuals with data at age 20 years as juvenile onset
obese/overweight cases and controls, in the current study.
Moreover, as our statistical power to detect the large
ORs reported by Tabassum and colleagues was very
high (>90 % for variants with risk allele frequencies
>0.40, data not shown), our study design should have
enabled us to identify a large effect of these variants
on childhood/juvenile obesity, if it had been exerted
among Danish individuals.
The identified differences between the current study
results and those reported among Indian children [14, 15]
may be due to the following reasons: firstly, the observed
phenotype at a given BMI cutoff is known to differ be-
tween various ethnic populations, and risk factors for
cardiovascular disease can be identified at a lower BMI in
Asian and Indian populations compared to European [48].
This suggests that applying the same BMI cut-off of
25 kg/m2 in both, the Indian and Danish populations may
confound the association. Furthermore, genotype frequen-
cies and LD patterns may differ between the populations,
and environmental factors such as lifestyle may also
modify the effects exerted by genetic variants. Finally,
population stratification may also play a role. Genetic
marker based clustering analyses have therefore been ap-
plied to exclude ethnic outliers in the current study as well
by Tabassum and colleagues [14, 15] ruling out the possi-
bility that major population stratification plays a role for
the observed differences between the two studies.
Conclusions
The current study illustrates that four variants (IL6
rs2069845, LEPR rs1137100, NAMPT rs3801266, and
AMD1 rs2796749) implicated in childhood obesity among
Indians are not strongly associated with obesity among
Danish children and juveniles.
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